يستعمل دواء اميوانت 250 / 190 وحدة دولية فيالimmunate 250 iu fviii / 190 iu vwf vial i.v. blood coagulation factor blood coagulation factor

immunate is a coagulation factor viii / von willebrand factor complex made from human plasma. the coagulation factor viii in immunate replaces the factor viii which is lacking or is not functioning properly in haemophilia a. haemophilia a is a sexlinked hereditary blood coagulation defect due to reduced factor viii levels. this results in severe bleeding in joints muscles and inner organs either spontaneously or as a consequence of accidental or surgical traumata. the administration of immunate -temporarily corrects the factor viii deficiency and reduces the bleeding tendency. -in addition to its role as a factor viii protecting protein von willebrand factor (vwf) mediates platelet adhesion to sites of vascular injury and plays a role in platelet aggregation. - -immunate is used for the treatment and prevention of bleeding in congenital (haemophilia a) or acquired factor viii deficiency. -immunate is also used in von willebrand�s disease with factor viii deficiency.